date:May 07, 2013
macular degenertion)) did not reach additional significant reduction in risk to the original AREDS formulation of progression to advanced AMD, a leading cause of adult blindness.
However, in a subgroup analysis comparing 10 mg FloraGLO Lutein and 2 mg of OPTISHARP Zeaxanthin with the groups given the original AREDS supplement, a statistically significant reduction in the progression to advanced AMD of 9% was seen for lutein and zeaxanthin in the entire study group.
Details are published in t